A long-term open-label safety study of galcanezumab in Japanese patients with migraine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A long-term open-label safety study of galcanezumab in Japanese patients with migraine
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2021-01-05
DOI
10.1080/14740338.2021.1866536
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
- (2020) Mark E. Bangs et al. BMC Neurology
- Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
- (2020) Virginia L. Stauffer et al. JOURNAL OF HEADACHE AND PAIN
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
- (2019) Virginia L. Stauffer et al. HEADACHE
- The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016
- (2019) Kia Vosoughi et al. JOURNAL OF HEADACHE AND PAIN
- Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data
- (2019) Juliana L Meyers et al. CEPHALALGIA
- Migraine: a major debilitating chronic non-communicable disease in Brazil, evidence from two national surveys
- (2019) Mario Fernando Prieto Peres et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
- (2019) Bianca Raffaelli et al. JOURNAL OF HEADACHE AND PAIN
- Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme
- (2019) Kaname Ueda et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
- (2018) Yuhan Zhu et al. NEUROLOGICAL SCIENCES
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies
- (2017) Matthieu Picard et al. Journal of Allergy and Clinical Immunology-In Practice
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies
- (2015) S. Sacco et al. EUROPEAN JOURNAL OF NEUROLOGY
- Drug safety and tolerability in prophylactic migraine treatment
- (2015) László Vécsei et al. Expert Opinion On Drug Safety
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Noncancer Pain Conditions and Risk of Suicide
- (2013) Mark A. Ilgen et al. JAMA Psychiatry
- Migraine Headaches and Suicide Attempt
- (2012) Naomi Breslau et al. HEADACHE
- Co-morbidity of migraine with somatic disease in a large population-based study
- (2010) Han Le et al. CEPHALALGIA
- Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
- (2010) AM Blumenfeld et al. CEPHALALGIA
- Pain and Risk of Completed Suicide in Japanese Men: A Population-Based Cohort Study in Japan (Ohsaki Cohort Study)
- (2008) Nobutaka Kikuchi et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now